Related Experiment Video
Updated: Jul 12, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
[New therapeutic guidelines in cardiology]
V Legrand1, P Lancellotti, A Waleffe
1CHU Sart-Tilman, Liège.
Revue Medicale De Liege
|August 30, 2007
Summary
Cardiovascular diseases (CVDs) are a major cause of death. This article reviews recent therapeutic options for CVDs, including coronary artery disease, valvular diseases, and atrial fibrillation, emphasizing physician knowledge and application of guidelines.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Cardiovascular diseases (CVDs) represent the primary cause of mortality in industrialized nations.
- Effective CVD management is crucial and requires physicians to be updated on current guidelines.
- International cardiology societies regularly publish and update clinical recommendations.
Purpose:
- To provide an overview of recent therapeutic advancements in managing select cardiovascular diseases.
- To highlight the importance of adhering to updated European and American cardiology guidelines.
Summary:
- This article discusses current therapeutic strategies for prevalent cardiovascular conditions.
- Key areas covered include coronary artery disease, valvular heart disease, and atrial fibrillation.
- It also touches upon implantable defibrillator therapy, acknowledging the scope is not exhaustive.
Impact:
- Enhances physician understanding of contemporary cardiovascular disease management.
- Supports the implementation of evidence-based practices for improved patient outcomes.
- Aims to improve the clinical approach to cardiovascular diseases based on updated recommendations.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...